Profile
Wendy Chapman, who previously worked at PAREXEL International Corp., YM BioSciences, Inc., and Viventia Biotech, Inc., held senior positions in clinical operations and portfolio direction.
She was also the Chief Operating Officer and Vice President of Clinical Operations at Viventia Biotech, Inc. Most recently, she served as the Senior Vice President of Clinical Operations at Sierra Oncology, Inc. from 2014 to 2022.
Former positions of Wendy Chapman
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 2022-06-30 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Chief Operating Officer | - |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
- Stock Market
- Insiders
- Wendy Chapman
















